TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,482 | -25.9% | 95 | -37.1% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 151 | 0.0% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 151 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | 0.0% | 151 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 151 | 0.0% | 0.00% | – |
| Q3 2021 | $2,000 | -33.3% | 151 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $3,000 | -50.0% | 151 | -52.4% | 0.00% | -50.0% |
| Q1 2021 | $6,000 | 0.0% | 317 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $6,000 | 0.0% | 317 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $6,000 | +100.0% | 317 | +109.9% | 0.00% | +100.0% |
| Q2 2020 | $3,000 | +50.0% | 151 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $2,000 | -84.6% | 151 | -77.6% | 0.00% | -80.0% |
| Q4 2019 | $13,000 | -31.6% | 674 | -38.1% | 0.01% | -16.7% |
| Q3 2019 | $19,000 | +280.0% | 1,088 | +270.1% | 0.01% | +200.0% |
| Q2 2019 | $5,000 | -37.5% | 294 | -22.0% | 0.00% | 0.0% |
| Q1 2019 | $8,000 | – | 377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |